These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23331771)

  • 1. HLA-DRB1 typing by micro-bead array assay identifies the origin of early lymphoproliferative disorder in a heart transplant recipient.
    Fedrigo M; Poli F; Esposito G; Feltrin G; Toscano G; d'Agostino C; Schiavon B; Gerosa G; Amadori A; Valente M; Thiene G; Angelini A
    Am J Transplant; 2013 Mar; 13(3):802-7. PubMed ID: 23331771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation.
    Murray DL; Pereira NL; Miller DV
    J Heart Lung Transplant; 2008 Nov; 27(11):1257-61. PubMed ID: 18971100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation.
    Choquet S; Varnous S; Deback C; Golmard JL; Leblond V
    Am J Transplant; 2014 Apr; 14(4):857-66. PubMed ID: 24666832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant Lymphoproliferative Disorders: A Rare Case of Primary Pericardial Involvement Epstein-Barr Virus-Correlated in Heart Transplantation.
    Toscano G; Fabozzo A; Fedrigo M; Gambino A; Angelini A; Gerosa G
    Transplant Proc; 2015 Sep; 47(7):2287-90. PubMed ID: 26361701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
    Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated pleural PTLD after cardiac transplantation.
    Lamba M; Jabi M; Padmore R; Sengar DP; Veinot JP
    Cardiovasc Pathol; 2002; 11(6):346-50. PubMed ID: 12459436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
    Abu-Farsakh H; Cagle PT; Buffone GJ; Bruner JM; Weilbaecher D; Greenberg SD
    Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
    Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
    Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
    Kuno M; Ito A; Maeshima AM; Taniguchi H; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
    Int J Hematol; 2020 Aug; 112(2):193-199. PubMed ID: 32472530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation.
    Petit B; Le Meur Y; Jaccard A; Paraf F; Robert CL; Bordessoule D; Labrousse F; Drouet M
    Transplantation; 2002 Jan; 73(2):265-71. PubMed ID: 11821742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
    Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
    Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.
    Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA
    Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.
    Drachenberg CB; Abruzzo LV; Klassen DK; Bartlett ST; Johnson LB; Kuo PC; Kumar D; Papadimitriou JC
    Hum Pathol; 1998 Jun; 29(6):569-77. PubMed ID: 9635676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.
    Leyssens A; Dierickx D; Verbeken EK; Tousseyn T; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verleden GM; Van Raemdonck DE; Vos R
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28383790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.
    Chinnock R; Webber SA; Dipchand AI; Brown RN; George JF;
    Am J Transplant; 2012 Nov; 12(11):3061-8. PubMed ID: 23072522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.
    Jamalidoust M; Geramizadeh B; Pouladfar G; Namayandeh M; Asaie S; Aliabadi N; Nikeghbalian S; Ziyaeyan M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():306-11. PubMed ID: 25894179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
    Börcek P; Özdemir BH; Özgün G; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.